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Rabies developed in an Austrian man after he was bit-
ten by a dog in Agadir, Morocco. Diagnosis was confirmed
by reverse transcription–polymerase chain reaction and
immunohistochemistry. The patient’s girlfriend was bitten
by the same dog, but she did not become ill.
R
abies is an acute, progressive, fatal encephalomyelitis
that can be prevented by vaccination. It is almost
always transmitted by the bite of an infected animal and is
still a public health problem in many countries in Africa
and Asia. Travelers with extensive unprotected outdoor
exposure, such as camping, in areas where rabies is
endemic are also at high risk (1). We report a case of rabies
associated with a dog bite in Agadir, Morocco, in an
Austrian man.
The Case
Two Austrian tourists (a 23-year-old man and a 21-
year-old woman) traveled to Morocco in May 2004. At the
end of July, they were staying in Agadir, Morocco, where
they played with puppies on the beach. One puppy was
aggressive and bit the woman on the third finger of her
right hand. While attempting to assist her, the man was
also bitten on the right hand and leg. The wounds healed
without further treatment, and the young people did not
seek medical assistance. Three days after the bite, the dog
died and was buried by the tourists. Four weeks later, the
man became ill with a temperature up to 39°C, malaise,
pain in the right arm, headache, feeling of extreme dryness
in the mouth, and difficulty swallowing. Two days later, he
was admitted to a hospital in the Spanish enclave of Ceuta,
where he additionally showed hydrophobia, aerophobia,
agitation, and increased salivation. Subsequently, hyper-
ventilation, decreased blood pressure of 85/45 mm Hg,
heart rate of 150 beats/min, markedly increased salivation,
and a generalized tremor developed.
The patient was transferred to the intensive care unit,
intubated, mechanically ventilated, and treated with intra-
venous fluids, dopamine, ampicillin, cefotaxime, and van-
comycin because of hypotension and pneumonia. The
patient’s history suggested rabies, and he and his girl-
friend (who was healthy) received rabies vaccination and
human rabies immunoglobulin (20 IU/kg intramuscularly
in the gluteal area). Three days after admission to the
Spanish hospital, the patient was transferred by air ambu-
lance to the intensive care unit at the Medical University
of Graz, Austria. Critical care management, treatment of
pneumonia with vancomycin and cefotaxime, and admin-
istration of rabies vaccine (Rabipur, Chiron, Marburg,
Germany), following the 0-, 3-, 7-, 14-, 28-day regimen,
were continued. In addition to remifentanil and midazo-
lam, ketamine was administrated. According to recent rec-
ommendations, we did not use ribavirin or interferon-α
(2). Skin biopsy specimens from the neck and cere-
brospinal fluid, pharyngeal swab, nasal swab, and serum
specimens were sent to the National Reference Laboratory
for Rabies (Austrian Agency for Health and Food Safety,
Institute for Veterinary Disease Control, Mödling,
Austria) and to the rabies laboratory at the Centers for
Disease Control and Prevention (CDC), Atlanta, Georgia,
USA.
Skin and pharyngeal swab were positive by reverse
transcription–polymerase chain reaction, showing 965-bp
(Mödling) and 300-bp (CDC) DNA amplicons of the
rabies virus nucleoprotein gene closely related to other
strains from Morocco (GenBank accession nos. U22852,
U22642, AY 062090, and U22631) (3). In addition, fluo-
rescence antibody test results and immunohistochemical
investigation of the neck biopsy specimen were positive
(Figures 1 and 2). Similar test results were also obtained
from the Spanish National Center of Microbiology,
Instituto de Salud Carlos III, Madrid, which received the
patient’s samples from Ceuta. Rabies serum antibody tests
performed 4 and 20 days after onset of symptoms showed
0.38 U/mL and 52.09 U/mL, respectively. The neurologic
symptoms of rabies worsened in the intensive care unit in
Graz until pupils did not react to light. Twenty days after
admission, 2 different electroencephalograms showed no
brain activity, and life support was discontinued. The
patient died 21 days after admission to our hospital and 27
days after onset of rabies symptoms. 
Since the female Austrian tourist was bitten by the same
rabid dog, she was also admitted to the Medical University
of Graz and received a thorough examination and psycho-
logical support. No abnormalities were found. Rabies vac-
cination, which had been started in Ceuta, was continued,
and she was released from the hospital in healthy condi-
tion. One week after complete vaccination, her antibody
titer was 118.53 U/mL. She remained healthy 4 months
after the bite and is currently being monitored.
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Our patient acquired rabies from a dog bite in July 2004
in Agadir, Morocco. On September 1, 2004, the World
Health Organization announced that a rabid dog had been
illegally imported into France from Agadir in July 2004.
The dog was aggressive and bit several persons who were
later contacted by French health authorities to assess their
risk for infection and provide professional help, but no
case of rabies associated with this dog has been reported to
date (4,5). Our patient’s dog bite–associated case of rabies
underlines the potential risk for infection by dogs from
Agadir and other rabies-endemic areas (4,5). This case of
rabies is the first to be diagnosed and treated in Austria
since 1979. Because of official rabies vaccination policy,
Austrian domestic and wild animals have been free of
rabies since 1995, with rare exceptions. Rabid foxes occa-
sionally immigrate to Austria, as was the case in 2002 on
the Carinthian-Slovenian border, and transmit rabies to
other animals (foxes, deer, dogs, cats, badgers) (6–8). The
occasional reappearance of rabies in Austria usually leads
to vaccination campaigns in relevant areas; these cam-
paigns, in combination with routine animal vaccination,
prevent the dissemination of rabies (6). The general public
in Austria thus does not consider rabies to be a serious
problem, and recommendations for vaccination for travel-
ers to rabies-endemic countries are sometimes ignored.
Although preexposure rabies prophylaxis is recom-
mended for travelers to Morocco (9), our patient and his
girlfriend did not receive vaccination before their trip.
They did also not seek medical assistance or receive post-
exposure prophylaxis immediately after the bites because
they did not understand the enormous potential risk from a
dog bite in a country where rabies is endemic. After the
patient showed symptoms indicative of rabies 1 month
later, he and his girlfriend were admitted to a hospital and
received passive and active postexposure prophylaxis.
Whereas the lethal course of the disease could not be pre-
vented in the man, the woman remained healthy, and high
levels of rabies antibodies developed. However, in 5% of
rabies cases the incubation period exceeds 1 year (10).
Since this young woman was bitten by the same dog that
transmitted rabies to our patient, she is still being followed.
Our case of travel-associated rabies in an Austrian man
underscores the importance of adhering to vaccination rec-
ommendations and the need for providing detailed infor-
mation to travelers.
Recently, authorities have recommended that molecular
diagnostic methods with samples from several sources be
performed and repeated until the diagnosis of rabies is
established. However, molecular diagnostic methods,
although useful and sensitive, may not always give posi-
tive results for patients with rabies (11). This lack of sen-
sitivity may be due to the intermittency of virus shedding,
the timing of sample collection, and the type of specimens
collected. For this reason and in concordance with CDC
recommendations, we suggest that immunohistochemical
investigation of skin biopsy specimens should be per-
formed for antemortem diagnosis of rabies, as we did with
our patient (12). 
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Figure 1. Immunohistochemical stain of neck biopsy specimen.
Note positive cells with small intracytoplasmic granules at the bor-
der of stratum granulosum and stratum corneum of the epidermis.
Bar = 20 µm.
Figure 2. Immunohistochemical stain of neck biopsy specimen.
Note the positive cell in the center with small intracytoplasmic
granules at the border of stratum granulosum and stratum
corneum of the epidermis. On the right side, melanin-rich epider-
mal cells are seen. Bar = 10 µm.References
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